SCHEMBL5724959

SCHEMBL5724959

CCOc1ccccc1CNC(C)=O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.59
MEN1 O00255 3/20 0.59
KMT2A Q03164 3/20 0.59
GAA P10253 2/20 0.59
ALOX15 P16050 2/20 0.59
USP2 O75604 1/20 0.59
PKM P14618 1/20 0.59
HSD17B10 Q99714 1/20 0.59
ALDH1A1 P00352 5/20 0.56
THRB P10828 2/20 0.55
L3MBTL1 Q9Y468 4/20 0.55
MAPT P10636 4/20 0.55
ATM Q13315 3/20 0.55
RECQL P46063 1/20 0.55
BLM P54132 1/20 0.55
PLEC Q15149 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
KDM4E B2RXH2 2/20 0.55
HPGD P15428 2/20 0.55
NPSR1 Q6W5P4 3/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2936375 0.87 LMNA (0.59) LMNAMEN1KMT2AGAAALOX15
SCHEMBL16437111 0.86 TSHR (0.53) LMNAMEN1KMT2AGAAALOX15
SCHEMBL29676259 0.84 MTNR1A (0.51) LMNAMEN1KMT2AGAAALOX15
SCHEMBL13702402 0.84 MEN1 (0.64) LMNAMEN1KMT2AGAAALOX15
SCHEMBL13702287 0.84 MEN1 (0.64) LMNAMEN1KMT2AGAAALOX15
SCHEMBL885000 0.83 MTNR1A (0.71) MEN1KMT2AGAAALDH1A1KDM4E
SCHEMBL5685631 0.83 HPGD (0.69) LMNAMEN1KMT2AGAAALOX15
SCHEMBL8479171 0.81 LMNA (0.54) LMNAMEN1KMT2AGAAALOX15
SCHEMBL26698320 0.81 ALDH1A1 (0.51) MEN1KMT2AGAAALDH1A1HPGD
SCHEMBL13702179 0.80 GAA (0.60) LMNAMEN1KMT2AGAAALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1633715-A1 2-(6-AMINO-PYRIDIN-3-YL)-2-HYDROXYETHYLAMINE DERIVATIVES AS BETA 2-ADRENOCEPTORS AGONISTS Pfizer Limited (GB) 2006-03-15 EP claimed
WO-2004108676-A1 2-(6-AMINO-PYRIDIN-3-YL)-2-HYDROXYETHYLAMINE DERIVATIVES AS BETA 2-ADRENOCEPTORS AGONISTS PFIZER LIMITED (GB) 2004-12-16 WO claimed
US-9150582-B2 Composition and method for neuropeptide S receptor (NPSR) antagonists RESEARCH TRIANGLE INSTITUTE (US) 2015-10-06 US disclosed
US-20150057268-A1 COMPOSITION AND METHOD FOR NEUROPEPTIDE S RECEPTOR (NPSR) ANTAGONISTS RESEARCH TRIANGLE INSTITUTE (US) 2015-02-26 US disclosed
WO-2013086200-A1 COMPOSITION AND METHOD FOR NEUROPEPTIDE S RECEPTOR (NPSR) ANTAGONISTS RESEARCH TRIANGLE INSTITUTE (US) 2013-06-13 WO disclosed
EP-1633715-A1 2-(6-AMINO-PYRIDIN-3-YL)-2-HYDROXYETHYLAMINE DERIVATIVES AS BETA 2-ADRENOCEPTORS AGONISTS Pfizer Limited (GB) 2006-03-15 EP disclosed
WO-2004108676-A1 2-(6-AMINO-PYRIDIN-3-YL)-2-HYDROXYETHYLAMINE DERIVATIVES AS BETA 2-ADRENOCEPTORS AGONISTS PFIZER LIMITED (GB) 2004-12-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150057268-A1 COMPOSITION AND METHOD FOR NEUROPEPTIDE S RECEPTOR (NPSR) ANTAGONISTS NPSR1, TACR1, NPFFR1 LMNA 1925/4885MEN1 2125/4885KMT2A 4585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.